Dr. Modesitt is the Director of the Gynecologic Oncology Division and the Co-Director of the High Risk Breast/Ovarian Cancer clinic at the University of Virginia. She is an Associate Professor and the Richard and Louise Crockett endowed Chair in Obstetrics and Gynecology. She completed her residency at the University of North Carolina and her fellowship at the M.D. Anderson Cancer Center. Dr. Modesitt served the Society of Gynecologic Oncology as Vice Chair of the Practice Survey Task force, Chair of the Candidate Task force and an Education Committee member. She was appointed to the Prolog Task force and Gynecologic Oncology Subcommittee for the American College of Obstetricians and Gynecologists. Dr. Modesitt is the UVA PI for the Gynecologic Oncology Group and is on the Safety Review and Developmental Therapeutics committees. Her research focuses on obesity related cancers, clinical trials and hereditary cancers.
Community outreach played an important role in the 2018 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, held March 24-27 in New Orleans.
September is Gynecologic Cancer Awareness Month. After creating the month in 1999, the Foundation strives to bring attention about these cancers through public awareness campaigns.